Send to a Friend Font Size: Increase Decrease

Clough Capital

Clough Capital's Portfolio

Last Updated on 5/17/11 @ 02:48pm

Ticker	# of Shares	Price	Value
	2,369,905	$1,141.93	$2,706,265,617
	1,260,697	$1,141.93	$1,439,627,726
	1,242,752	$1,141.93	$1,419,135,792
	1,070,900	$1,141.93	$1,222,892,837
	786,100	$1,141.93	$897,671,173
	529,110	$1,141.93	$604,206,583
	510,382	$1,141.93	$582,820,518
	507,500	$1,141.93	$579,529,475
	495,530	$1,141.93	$565,860,573
View Additional Portfolio Information »

Clough Capital Clough is a Boston-based investment advisory firm which manages approximately $3.9 billion in assets: $1.7 billion in hedge fund and institutional accounts; $92 million in open-end mutual funds; and $2.1 billion in three closed-end funds (as of February 28, 2011) - Clough Global Allocation (GLV), Clough Global Equity (GLQ), and the Clough Global Opportunities Fund (GLO). The firm uses a global and theme-based approach and invests in securities on a global basis. Clough was founded in 2000 by Chuck Clough and partners James Canty and Eric Brock. These three are the portfolio managers for the Clough Global Allocation Fund.

Login to help us fill in information about this entity.

Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31 Feb 14, 2024 01:03PM

Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30 Nov 14, 2023 02:28PM

Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30 Aug 14, 2023 08:00AM

Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31 May 15, 2023 12:13PM

Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31 Feb 14, 2023 10:39AM

View Older Stories

Feb 9, 2023 12:34PM Form 4 Clough Global Dividend For: Feb 08 Filed by: Clough Capital Partners, L.P.
Feb 9, 2023 12:28PM Form 4 Clough Global Equity For: Feb 08 Filed by: Clough Capital Partners, L.P.
Feb 9, 2023 12:23PM Form 4 Clough Global Opportunit For: Feb 08 Filed by: Clough Capital Partners, L.P.
Nov 14, 2022 12:17PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 16, 2022 09:22AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 16, 2022 12:17PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Feb 14, 2022 11:05AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 14, 2022 10:16AM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Dec 21, 2021 05:13AM Sanofi (SNY) Acquires Amunix Immuno-Oncology Pipeline with Next-Gen Conditionally Activated Biologics
Nov 15, 2021 03:06PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 16, 2021 10:58AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
Jul 2, 2021 10:34AM Form 4 Clough Global Opportunit For: Jun 30 Filed by: Clough Capital Partners, L.P.
Jul 2, 2021 10:26AM Form 4 Clough Global Equity For: Jun 30 Filed by: Clough Capital Partners, L.P.
Jul 2, 2021 10:13AM Form 4 Clough Global Dividend For: Jun 30 Filed by: Clough Capital Partners, L.P.
May 24, 2021 04:03PM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
May 20, 2021 08:25PM Form 4 Clough Global Dividend For: May 19 Filed by: Clough Capital Partners, L.P.
May 17, 2021 12:50PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Feb 16, 2021 12:49PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 12, 2021 12:22PM Form SC 13G/A Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Nov 17, 2020 06:03AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Nov 10, 2020 02:55PM Form SC 13G Checkmate Pharmaceutical Filed by: CLOUGH CAPITAL PARTNERS L P
Aug 27, 2020 05:00PM Form 4 Clough Global Equity For: Aug 26 Filed by: Clough Capital Partners, L.P.
Aug 27, 2020 04:06PM Form 4 Clough Global Opportunit For: Aug 26 Filed by: Clough Capital Partners, L.P.
Aug 14, 2020 12:48PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 15, 2020 10:23AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Feb 24, 2020 08:34AM Form SC 13G Correvio Pharma Corp. Filed by: CLOUGH CAPITAL PARTNERS L P
Feb 14, 2020 03:45PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Nov 14, 2019 03:09PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 14, 2019 06:17AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 15, 2019 03:49PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Feb 14, 2019 10:32AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 14, 2019 10:30AM Form SC 13G Correvio Pharma Corp. Filed by: CLOUGH CAPITAL PARTNERS L P
Nov 14, 2018 02:40PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 14, 2018 09:02AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 15, 2018 04:05PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Apr 27, 2018 03:10PM Form SC 13G/A CARVANA CO. Filed by: CLOUGH CAPITAL PARTNERS L P
Apr 27, 2018 03:08PM Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
Feb 14, 2018 12:04PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Feb 13, 2018 01:27PM Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
Feb 13, 2018 01:26PM Form SC 13G CARVANA CO. Filed by: CLOUGH CAPITAL PARTNERS L P
Nov 14, 2017 10:06AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 14, 2017 12:07PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 15, 2017 05:33PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Feb 15, 2017 06:04AM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Nov 14, 2016 03:28PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Sep 30
Aug 15, 2016 12:28PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Jun 30
May 16, 2016 06:54PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Mar 31
Mar 22, 2016 04:21PM Form SC 13G/A Cardiome Pharma Corp Filed by: CLOUGH CAPITAL PARTNERS L P
Feb 16, 2016 04:58PM Form 13F-HR CLOUGH CAPITAL PARTNERS For: Dec 31
Jan 12, 2016 09:41AM Form SC 13G/A VERACYTE, INC. Filed by: CLOUGH CAPITAL PARTNERS L P

View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed